Tesaro reports positive test results By: MarketMinute.com Stock News June 29, 2016 at 16:49 PM EDT Tesaro Inc. (Nasdaq: TSRO) reported positive results from a Phase 3 NOVA trial of niraparib to treat ovarian cancer sending the stock price soaring $40.19 to close at $77.40. Related Stocks: Tesaro Inc